Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767936 · ClinicalTrials.gov registry record
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 135
- Enrollment target
NCT00767936: Clinical Trial study, sponsored by Stanford University.
NCT00767936 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 135 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767936 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 135 participants
- Enrollment target
Study Summary
Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.
Primary Outcome
We will be using blood specimens collected through another protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-09 |
Why NCT00767936 stopped before completion
NCT00767936 is an observational study that tracks outcomes without assigning an intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00767936 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00767936 about?
NCT00767936 is a clinical study titled "Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma". Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chron...
What is the current status of trial NCT00767936?
This trial is currently terminated. The enrollment target is 135 participants. The study started on 2008-03. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT00767936?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia